Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (TSX:RY)

180.37 -1.96 (-1.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
2 Profitable Stocks with Promising Prospects and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Cybersecurity Stocks: Artificial Intelligence Dominates RSA Conference But Monetization Still In Question
The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends. 
Via Investor's Business Daily
Topics Artificial Intelligence
2 Cash-Producing Stocks with Competitive Advantages and 1 to Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Price Over Earnings Overview: RBC Bearings
Via Benzinga
Palantir's Government, Commercial Business Trends Eyed In Q1 Earnings
Palantir reports Q1 earnings on Monday, the data analytics software maker's government and commercial businesses will again be in focus. 
Via Investor's Business Daily
Topics Artificial Intelligence Earnings
Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today
Via Benzinga
Visa's Q2 Results Reflect Steady US Spending Despite Market Uncertainty: Analyst Highlights Strength In Payment Volumes
Visa gains after RBC's Perlin highlights strong Q2 results, steady U.S. spending, and a $30B buyback plan. 
Via Benzinga
BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market. 
Via Investor's Business Daily
1 Industrials Stock to Consider Right Now and 2 to Approach with Caution
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Stocks
DoorDash's Deliveroo Offer Seen As 'Meaningfully Expanding' Global Reach
DoorDash stock analysts were mostly positive on the company's offer to acquire U.K.-focused food delivery firm Deliveroo. 
Via Investor's Business Daily
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
Did Google Earnings Results Put Search Worries To Rest? Here's What Analysts Are Saying
Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format. 
Via Investor's Business Daily
Topics Artificial Intelligence
Unpacking Q4 Earnings: RBC Bearings (NYSE:RBC) In The Context Of Other Engineered Components and Systems Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at RBC Bearings (NYSE:RBC) and the best and... 
Via StockStory
Google Earnings Due. Here's What Could Move Alphabet Stock.
Google stock has retreated 20% in 2025 heading into Alphabet's Q1 earnings report. Google's internet search business is still top of mind for investors amid the rise of generative artificial... 
Via Investor's Business Daily
Topics Artificial Intelligence Economy
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
The company's commentary on tariffs was a "pleasant surprise," according to one analyst. 
Via Investor's Business Daily
Topics Economy Government World Trade
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Results
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions. 
Via Stocktwits
Topics Government
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plans
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives. 
Via Stocktwits
Topics World Trade
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly. 
Via Investor's Business Daily
Topics Government
American Express' Solid Revenue, Spending Trends Drive Analyst Optimism
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook. 
Via Benzinga
Looking Into RBC Bearings's Recent Short Interest
Via Benzinga
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
Consider buying these top-notch AI-powered stocks in the current market dip. 
Via The Motley Fool
Topics Artificial Intelligence
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
The companies are facing off with their heart drugs in a growing disease area. 
Via Investor's Business Daily
We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Interest
Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration. 
Via Stocktwits
Topics Bankruptcy Electric Vehicles Government
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care. 
Via Investor's Business Daily
Topics Government
Wall Street Analysts Are Slashing Their Stock Market Forecasts. Here's What You Should Do, According to History.
Via The Motley Fool
Topics Artificial Intelligence Economy Government
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78... 
Via Stocktwits
Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soars
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and... 
Via Stocktwits
Topics Intellectual Property
5 Consumer Stocks That Hit 52-Week Lows Last Week On Trump's Tariff Shockwaves
Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales. 
Via Stocktwits
Topics Economy Government Lawsuit
Woodside Energy In Spotlight After 40% Stake Sale In Louisiana LNG, Retail’s Bullish
Stonepeak will provide $5.7 billion for the development of Louisiana LNG on an accelerated basis. 
Via Stocktwits
Topics World Trade
Badger Meter Gets an Upgrade—2 Stocks That Could Follow
RBC analysts just boosted Badger Meter stock, but the broader theme behind this view might lead investors to other similar opportunities. 
Via MarketBeat
Topics Economy Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.